Intended for teachers, the article provides an introduction to the four major classes of psychotropic medication (stimulants, tranquilizers, anticonvulsants, and antidepressants) commonly prescribed for children with learning or behavioral disorders. Specific effects on the classroom are addressed. (DB)

Discusses the potential uses of psychopharmarcologic therapy with students who are diagnosed with autism, Tourette syndrome, or pervasive developmental disorders and who display learning, emotional, or behavioral disorders. Explores the possible benefits and known negative side effects associated with 10 classes of drugs used for such treatment.…

This article raises four issues in the education of students with emotional and/or behavioral disorders. These are: (1) misidentification, (2) diagnostic omission of comorbidity, (3) psychopharmacologic under treatment, and (4) misunderstanding of developmental psychopathology. (Contains references.) (DB)

Summarizes recent findings from a meta-analysis on the use and effectiveness of medication as a treatment for ADHD. Expresses concern that teachers and parents may not fully realize that stimulants are still a crucial part of the overall treatment for these children. Concludes that psychological intervention can be complemented with intervention…

Although many psychopharmacologic treatments and behavioral or cognitive behavioral interventions have been established as evidence-based practices, they have seldom been directly compared to one another as to outcome in children with emotional or behavioral disorders (EBD). In this paper, we present findings from 6 recent randomized clinical…

Discusses the potential uses and abuses of psychopharmacologic therapy with children or adolescents who display learning, emotional, or behavioral disorders. Explores the indications and contraindications of such therapy and enumerates the known side effects of the most frequently prescribed medications, including psychostimulants,…

The author urges the field of education for children with emotional or behavioral disorders to address three critical areas: (1) developmental psychopathology (to improve early identification and prevention); (2) psychiatric comorbidity (e.g., disruptive disorders present with depression or anxiety disorder); and (3) psychopharmacology (especially…

This article reviews evidence on the treatment and comorbidity of psychiatric disorders with the purpose of suggesting odds that a child with behavioral disorder may indeed have a disorder that is responsive to psychopharmacologic treatment. Merging the medical and behavioral models is suggested as critical to special education decisions.…

This study examined the sustained effects of methylphenidate on reading performance in 42 boys (ages 8 to 11) with attention deficit-hyperactivity disorder, either with or without conduct disorders. Only the subgroup of those with conduct disorders responded, and significant reading improvement was exhibited in only a subgroup of these students.…

Briefly reviews recent findings and trends in the use of stimulant medication for attention-deficit hyperactivity disorder as well as other psychopharmacologic medications for mood, anxiety, or schizophrenic disorders, and concludes with a discussion of how to improve the use of such medications in school situations. (Author/CR)

The original authors of an article proposing a new medical model of special education for children with emotional or behavioral disorders respond to comments by considering: (1) the role of psychiatric diagnosis in special education, (2) the relative efficacy of behavioral versus psychopharmacologic treatment, and (3) the nature of…

Twenty-seven boys (ages 8-11) with hyperactive disorder and 28 boys with hyperactive-aggressive disorder were administered methylphenidate. No significant results were found for the hyperactive disorder group in either reading recognition or comprehension. The hyperactive-aggressive group improved in reading comprehension, with no effect resulting…

A study compared 422 Head Start children with a putative diagnosis of attention deficit hyperactivity disorder (ADHD) with typical Head Start children from kindergarten through third grade. Children with putative ADHD who had received medications were significantly more likely to be found eligible for special education than non-medicated children.…

Noting the high incidence of attention deficit hyperactivity disorder (ADHD) in programs for children with emotional disturbances or learning disabilities, this article reviews evidence that comorbid diagnoses affect outcomes differentially and that psychopharmacologic treatments may be superior to behavioral interventions, depending on this…

This study examined response to treatment with methylphenidate (Ritalin) across 6 measures of cognitive, academic, and social functioning in 71 boys (ages 7-11) with attention deficit hyperactivity disorder. Response ranged from 18 percent to 71 percent across the six measures, suggesting that classifying a child as a responder to methylphenidate…